HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ-GM:IMMC) announced today that, on January 23, 2008, it received a notice from The Nasdaq Stock Market indicating that, as of January 23, 2008, Immunicon’s minimum bid price had fallen below $1.00 for 30 consecutive business days and that its securities are, therefore, subject to delisting from the Nasdaq Capital Market. Nasdaq Marketplace Rule 4310(c)(4) requires a $1.00 minimum bid price for continued listing of an issuer’s common stock. Accordingly, Nasdaq staff are reviewing Immunicon’s eligibility for continued listing on the Nasdaq Capital Market.
